Mekinist Trametinib Tablets In Pakistan
Mekinist is a targeted cancer therapy containing trametinib, used to treat certain types of advanced or metastatic cancers, particularly melanoma with specific genetic mutations such as BRAF V600E or V600K. It may also be prescribed for other cancers, including non-small cell lung cancer (NSCLC), when used in combination with other targeted treatments.
Mekinist works by inhibiting MEK proteins in the MAPK/ERK pathway, which are involved in cell growth and division. By blocking this pathway, it helps slow down or stop the growth of cancer cells and can reduce tumor size.
Key Benefits:
Targets cancer cells with specific genetic mutations
Helps slow or stop tumor growth
Often used in combination with other therapies for improved effectiveness
May improve survival outcomes in certain cancers
Ingredients
Each tablet of Mekinist contains:
Active Ingredient: Trametinib 2mg
Inactive Ingredients: Mannitol, microcrystalline cellulose, hypromellose, magnesium stearate, sodium starch glycolate, titanium dioxide, and iron oxide (coloring agent)
How to Use:
Mekinist tablets should be taken exactly as prescribed by an oncologist, usually once daily on an empty stomach (at least 1 hour before or 2 hours after a meal). Do not crush or chew the tablets.
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
1.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
_600mg_Capsule.jpg)
.jpg)
.jpg)
_.jpg)
,_45g.jpg)
_250_.jpg)
.jpg)
.jpg)
_.jpg)
